A Crossover, Observational study to evaluate the efficacy of High‐dose influenza vaccine versus the Standard‐dose influenza vaccine in veterans ≥65 years of age
Latest Information Update: 24 Sep 2018
Price :
$35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 24 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management